Dedalus

Ardian has acquired approximately 60% of Dedalus Holding, owner of Dedalus, the highly regarded global clinical health software provider. The founder Giorgio Moretti has retained a 40% stake and will continue to lead the Company.

Over the years, thanks to a targeted acquisition strategy, which has resulted in 40 companies being acquired, and important investments in Research & Development, Dedalus has become an international company and an established leader in its field. Following the merger with NoemaLife, of which Dedalus recently acquired more than 83%, the company will become the leading player in clinical health software in Italy and one of the biggest in Europe, with a global reach across 25 countries. The Group expects to close 2016 with a turnover of approximately €170 million DVRCAPITAL acted as financial advisor to Dedalus | July 2016